Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Rank in Stocks
#4253
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Share Price
$2.24
Market Cap
$3.74B
Change (1 day)
0.59%
Change (1 year)
-8.63%
Country
CN
Trade Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Category
Healthcare
P/E ratio for Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
P/E ratio as of October 2026 TTM: 18.34
According to Shijiazhuang Yiling Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 18.34. At the end of 2023 the company had a P/E ratio of 28.50.
P/E ratio history for Shijiazhuang Yiling Pharmaceutical Co., Ltd. from 2008 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 18.34 | -149.68% |
| 2024 | -36.92 | -229.54% |
| 2023 | 28.50 | 34.53% |
| 2022 | 21.18 | -13.06% |
| 2021 | 24.37 | -2.39% |
| 2020 | 24.96 | 2.05% |
| 2019 | 24.46 | 24.48% |
| 2018 | 19.65 | -39.06% |
| 2017 | 32.25 | -8.61% |
| 2016 | 35.29 | -24.10% |
| 2015 | 46.49 | 2.08% |
| 2014 | 45.54 | -38.89% |
| 2013 | 74.52 | 8.89% |
| 2012 | 68.44 | 108.50% |
| 2011 | 32.82 | -30.92% |
| 2010 | 47.51 | -4.26% |
| 2009 | 49.63 | -58.89% |
| 2008 | 120.71 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 24.47 | 33.43% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| 223.52 | 1,118.65% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.